Antibody False Positivity Among COVID-19 Convalescent Plasma Donors: A Comparative Study from the Turkish Red Crescent Blood Center
- 1 November 2021
- journal article
- research article
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 59 (5), 353-357
- https://doi.org/10.4274/haseki.galenos.2021.7383
Abstract
Aim: During our routine work at the Turkish Red Crescent (TRC) laboratories, human deficiency virus (HIV) 1/2 antibody false-positive results were observed among Coronavirus disease-2019 convalescent plasma (CP) donors more frequently than healthy donors. We aimed to determine anti-HIV 1/2 antibody false-positivity rates among the CP donors and healthy blood donors. Methods: The present study was designed as a cross-sectional study which was a type of observational study. Total 3689 donations from 2593 donors donated CP to the TRC between 11 April-06 July 2020, were screened by electrochemiluminescence immunoassay for the presence of antibody against HIV 1/2. The confirmation tests were performed with line immunoassay. All of the donors were non-remunerated CP donors between the ages of 18-60. For the control group, 411078 donations from 407363 healthy blood donors were received on the same days. Results: Repeated reactivity rates (1.87%) were significantly higher than the control group (0.13%, p<0.05). However, there was not a statistically significant difference between the confirmed reactivity rates of the study group (0.03%) and the control group (0.01%, p=0.217). Conclusion: In our study, it was determined that the false-positive results obtained from serologic HIV screening tests of CP donors were significantly higher when compared to the healthy blood donors.Keywords
This publication has 8 references indexed in Scilit:
- False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infectionAIDS, 2021
- Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entryScientific Reports, 2021
- Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive resultsJournal of Clinical Pathology, 2020
- Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre ExperienceAntiviral Therapy, 2017
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Two-Way Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Group 1 Animal CoVs Is Mediated through an Antigenic Site in the N-Terminal Region of the SARS-CoV NucleoproteinJournal of Virology, 2007
- False positive antibody results against human T‐cell lymphotropic virus in patients with severe acute respiratory syndromeJournal of Medical Virology, 2005
- A serological survey on neutralizing antibody titer of SARS convalescent seraJournal of Medical Virology, 2005